Clinical Study of Self-gripping Mesh in TAPP Versus Lichtenstein Hernia Repair

February 2, 2024 updated by: Second Hospital of Jilin University

Clinical Study of Self-gripping Mesh in Transabdominal Preperitoneal (TAPP) Versus Lichtenstein Hernia Repair

The goal of this prospective study is to compare the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair, in order to improve the outcome of inguinal hernia treatment. The main question it aims to answer is, in which procedure is the self-gripping mesh more effective.

Participants will be divided into the TAPP group and the Lichtenstein group by random number table method, the TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair, and the Lichtenstein group underwent Lichtenstein hernia repair, both groups used self-gripping meshes.

Researchers will compare the operation time, postoperative time out of bed, postoperative hospital stay, hospital costs and postoperative complications between the two groups to see the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair.

Study Overview

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jilin
      • Changchun, Jilin, China, 130022
        • The Second Hospital of Jilin University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male patients aged 18 years and older.
  • Patients with a definite diagnosis of unilateral primary inguinal hernia.
  • Patients and their families were informed about the study protocol and agreed to participate in the study.

Exclusion Criteria:

  • Patients with femoral, recurrent, bilateral, incarcerated and strangulated hernias.
  • Patients with previous history of lower abdominal surgery.
  • Patients with contraindications to anaesthesia.
  • Patients with contraindications to laparoscopic surgery.
  • Failure to follow up patients as scheduled.
  • Patients with abdominal infections.
  • Those who cannot tolerate general anaesthesia surgery due to serious coagulation disorders, cardiopulmonary disorders, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TAPP group
The TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair.
The TAPP group used self-gripping mesh for laparoscopic transperitoneal preperitoneal hernia repair.
Experimental: Lichtenstein group
The Lichtenstein group underwent Lichtenstein hernia repair.
The Lichtenstein group used self-gripping mesh for Lichtenstein hernia repair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of moderate to severe pain at 3 and 6 months after surgery.
Time Frame: 3 and 6 months after surgery.
Visual analogue scale (VAS) was used to score the postoperative pain at 3 and 6 months. The score ranges from 0 (no pain) to 10 (most severe pain).
3 and 6 months after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of recurrent inguinal hernia at 3 and 6 months after surgery.
Time Frame: 3 and 6 months after surgery.
Recurrence of inguinal hernia after surgery
3 and 6 months after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

November 30, 2023

Study Completion (Actual)

November 30, 2023

Study Registration Dates

First Submitted

January 26, 2024

First Submitted That Met QC Criteria

January 26, 2024

First Posted (Actual)

February 5, 2024

Study Record Updates

Last Update Posted (Estimated)

February 6, 2024

Last Update Submitted That Met QC Criteria

February 2, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • (2022) Annual Audit No. (175)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data sharing with other researchers is not planned at this time due to patient privacy concerns.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inguinal Hernia

Clinical Trials on Laparoscopic transabdominal preperitoneal hernia repair.

Subscribe